Advanced search
Publication Cover
Emerging Microbes & Infections Volume 11, 2022 - Issue 1
Submit an article Journal homepage
1,865
Views
13
CrossRef citations to date
0
Altmetric
Coronaviruses

Reduced neutralization of SARS-CoV-2 Omicron variant by BNT162b2 vaccinees’ sera: a preliminary evaluation

D. Miletoa Laboratory of Clinical Microbiology, Virology and Bioemergencies, ASST Fatebenefratelli Sacco, L. Sacco University Hospital, Milan, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9414-0287
ORCID Icon,
V. Michelia Laboratory of Clinical Microbiology, Virology and Bioemergencies, ASST Fatebenefratelli Sacco, L. Sacco University Hospital, Milan, Italy
,
C. Feniziab Department of Biomedical and Clinical Sciences L. Sacco, University of Milan, Milan, Italy;c Department of Pathophysiology and Transplantation, University of Milan, Milan, ItalyORCID Iconhttps://orcid.org/0000-0003-0735-8331
ORCID Icon,
M. Cutreraa Laboratory of Clinical Microbiology, Virology and Bioemergencies, ASST Fatebenefratelli Sacco, L. Sacco University Hospital, Milan, Italy
,
G. Gagliardia Laboratory of Clinical Microbiology, Virology and Bioemergencies, ASST Fatebenefratelli Sacco, L. Sacco University Hospital, Milan, Italy
,
A. Mancona Laboratory of Clinical Microbiology, Virology and Bioemergencies, ASST Fatebenefratelli Sacco, L. Sacco University Hospital, Milan, ItalyORCID Iconhttps://orcid.org/0000-0002-1490-636X
ORCID Icon,
F. Bracchittaa Laboratory of Clinical Microbiology, Virology and Bioemergencies, ASST Fatebenefratelli Sacco, L. Sacco University Hospital, Milan, Italy
,
A. De Silvestrid Clinical Epidemiology and Biometeric Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
,
G. Rizzardinie Division of Infectious Diseases, ASST Fatebenefratelli Sacco, L. Sacco University Hospital, Milan, ItalyORCID Iconhttps://orcid.org/0000-0002-5183-7818
ORCID Icon,
A. Lombardia Laboratory of Clinical Microbiology, Virology and Bioemergencies, ASST Fatebenefratelli Sacco, L. Sacco University Hospital, Milan, Italy
,
M. Biasinb Department of Biomedical and Clinical Sciences L. Sacco, University of Milan, Milan, Italy
&
M. R. Gismondoa Laboratory of Clinical Microbiology, Virology and Bioemergencies, ASST Fatebenefratelli Sacco, L. Sacco University Hospital, Milan, Italy
 show all
Pages 790-792 | Received 13 Jan 2022, Accepted 19 Feb 2022, Published online: 10 Mar 2022

Figures & data

Figure 1. SARS-CoV-2 variants of concern (VOC). Panel (A) Neutralization assay (NTA) performed on the SARS-CoV-2 lineage B.1 (EU) and 2 VOCs, d and o. Panels B and C comparison between the Omicron variant and the EU and delta variant, respectively. Lines connect the NTAs of each individual subject. Panel D shows the correlation between anti-SARS-CoV-2 specific antibodies and neutralization assays (NTA) measured 1 month post two doses of the BNT162b2 vaccine. Three weeks after a third dose both antibody titres (Panel E) and neutralizing activity (NA) (Panel F) increased. **** = p <0.0001.

Figure 1. SARS-CoV-2 variants of concern (VOC). Panel (A) Neutralization assay (NTA) performed on the SARS-CoV-2 lineage B.1 (EU) and 2 VOCs, d and o. Panels B and C comparison between the Omicron variant and the EU and delta variant, respectively. Lines connect the NTAs of each individual subject. Panel D shows the correlation between anti-SARS-CoV-2 specific antibodies and neutralization assays (NTA) measured 1 month post two doses of the BNT162b2 vaccine. Three weeks after a third dose both antibody titres (Panel E) and neutralizing activity (NA) (Panel F) increased. **** = p <0.0001.

Data availability statement

The data that support the findings of this study are available from the corresponding author, D.M., upon reasonable request.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.